MedTrace Logo

Registry of Osteogenesis Imperfecta

NCT04115774 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-11-20

No results posted yet for this study

Summary

ROI is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc. This approach has been developed to corroborate and integrate data from different sources evaluating several aspects of diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate diseases pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.

Conditions

Interventions

DRUG

bisphosphonates

Since this is an observational study, the investigators collect general information on bisphosphonates treatment/impact

Sponsors & Collaborators

  • Luca Sangiorgi

    lead OTHER

Principal Investigators

  • Luca Sangiorgi, PhD · Istituto Ortopedico Rizzoli

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-28
Primary Completion
2018-07-31
Completion
2032-02-29

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04115774 on ClinicalTrials.gov